Celltrion concludes enrolment in global Covid-19 antibody trial
The trial will analyse the efficacy and safety of CT-P59 in combination with standard of care. Credit: fernando zhiminaicela from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
